Partitioning of Bronchopulmonary Carcinoids in Two Different Prognostic Categories by Ki-67 Score
Authors:
- Franco GrimaldiFGFranco Grimaldi
- Daniele MuserDMDaniele Muser
- Carlo Alberto BeltramiCBCarlo Alberto Beltrami
- Angelo MorelliAMAngelo Morelli
- Stefano PizzolittoSPStefano Pizzolitto
- Giovanni TalmassonsGTGiovanni Talmassons
- Francesca MarcielloFMFrancesca Marciello
- Annamaria Anita Livia ColaoAnnamaria Anita Livia Colao
- Guglielmo MonacoGMGuglielmo Monaco
- Antongiulio FaggianoAFAntongiulio Faggiano
Open Access
- 1 January 2011
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 2, 20
Abstract
Introduction: Histological distinction between typical and atypical bronchopulmonary carcinoids is based on mitotic activity and necrosis. Regardless of these two parameters, outcome after surgery is often unpredictable. In this study the prognostic value of different clinico-pathological factors was retrospectively analyzed in a large series of patients with bronchopulmonary carcinoid. Materials and Methods: The long-term post-surgical outcome of 106 radically treated patients affected by bronchopulmonary carcinoid from two Italian centers was correlated with tumor characteristics assessed by combining conventional histology with a panel of immunohistochemical markers of neuroendocrine differentiation (chromogranin-A, NSE) and proliferation activity (Ki-67 score). Results: Carcinoids were assessed as typical (TC = 75; 70.8%) and atypical (AC = 31; 29.2%). Mean follow-up was 8.3 years (range: 0–20; median: 8.0). All cases expressed neuroendocrine markers. At univariate analysis, tumor recurrence [14/75 TC (18.7%), 15/31 AC (48.4%)] correlated with carcinoid histotype (P = 0.003), tumor size (P = 0.012), mitotic index (P = 0.044), Ki-67 score (P < 0.0001), and synchronous node metastasis (P = 0.037). Of these, Cox multivariate analysis confirmed only Ki-67 score as independent predictor of disease recurrence (P = 0.009). The best cut-off for Ki-67 score (calculated by ROC curves) discriminating recurrent vs non-recurrent disease was 4% (sensitivity 79.3%; specificity 83.8%; area under the curve 0.85). By stratifying patients according to this cut-off, a significantly different disease-free survival was found (log-rank test P < 0.0001). Conclusion: Ki-67 score accurately separates bronchopulmonary carcinoids in two well-distinct histo-prognostic categories. Ki-67 score predicts the patients outcome better than mitotic count, histotype, and tumor stage and it is therefore helpful in establishing the appropriate follow-up.Keywords
This publication has 28 references indexed in Scilit:
- Proliferative activity in human breast cancer: Ki-67 automated evaluation and the influence of different Ki-67 equivalent antibodiesDiagnostic Pathology, 2011
- Accuracy of a remote quantitative image analysis in the whole slide imagesDiagnostic Pathology, 2011
- A comment on 'Theegarten et al.: Submesothelial deposition of carbon nanoparticles after toner exposition: Case report. Diagnostic Pathology 2010, 5:77'Diagnostic Pathology, 2011
- Reclassification of Neuroendocrine Tumors Improves the Separation of Carcinoids and the Prediction of SurvivalJournal of Thoracic Oncology, 2008
- The IASLC Lung Cancer Staging Project: Proposals for the Inclusion of Broncho-Pulmonary Carcinoid Tumors in the Forthcoming (Seventh) Edition of the TNM Classification for Lung CancerJournal of Thoracic Oncology, 2008
- Bronchopulmonary Carcinoid: Phenotype and Long-term Outcome in a Single-Institution Series of Italian PatientsClinical Cancer Research, 2008
- A 5‐decade analysis of 13,715 carcinoid tumorsCancer, 2003
- Neuroendocrine Lung Tumors: Grade Correlates with Proliferation but not AngiogenesisLaboratory Investigation, 2001
- Molecular Markers Help Characterize Neuroendocrine Lung TumorsThe Annals of Thoracic Surgery, 1996
- Carcinoid tumours of the bronchus: a 33 year experience.Thorax, 1984